FEVASTIN PLUS

Main information

  • Trade name:
  • FEVASTIN PLUS 10 TAB
  • Dosage:
  • 500,50;MG
  • Pharmaceutical form:
  • TAB
  • Composition:
  • 10
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FEVASTIN PLUS 10 TAB
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

1-2-2018

Scientific guideline:  Paracetamol oral use immediate release formulations product-specific bioequivalence guidance - First version, adopted

Scientific guideline: Paracetamol oral use immediate release formulations product-specific bioequivalence guidance - First version, adopted

This document provides product-specific guidance on the demonstration of the bioequivalence of paracetamol.

Europe - EFSA - European Food Safety Authority EFSA Journal

16-1-2018

Yunnan Feng Shi Ling capsules – counterfeit

Yunnan Feng Shi Ling capsules – counterfeit

Yunnan Feng Shi Ling capsules contain the undeclared substance paracetamol.

Therapeutic Goods Administration - Australia

19-1-2018

LACTICUM ACIDUM (Lactic Acid, Dl-) Liquid [Washington Homeopathic Products]

LACTICUM ACIDUM (Lactic Acid, Dl-) Liquid [Washington Homeopathic Products]

Updated Date: Jan 19, 2018 EST

US - DailyMed

17-1-2018

Omega 3 Fatty Acids

Omega 3 Fatty Acids

Omega 3 fatty acids are a lipid-regulating agent used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (500 mg/dL or greater) hypertriglyceridemia.

US - RxList

2-1-2018

SATOGESIC (Dl-Camphor, L-Menthol, Methyl Salicylate) Patch [Fuji Seal, Inc.]

SATOGESIC (Dl-Camphor, L-Menthol, Methyl Salicylate) Patch [Fuji Seal, Inc.]

Updated Date: Jan 2, 2018 EST

US - DailyMed

2-1-2018

SATOHAP PADS (Dl-Camphor, L-Menthol, Methyl Salicylate) Patch [Fuji Seal, Inc.]

SATOHAP PADS (Dl-Camphor, L-Menthol, Methyl Salicylate) Patch [Fuji Seal, Inc.]

Updated Date: Jan 2, 2018 EST

US - DailyMed

15-12-2017

News and press releases:  Modified-release paracetamol-containing products to be suspended from EU market

News and press releases: Modified-release paracetamol-containing products to be suspended from EU market

Recommendation endorsed due to the difficulty in managing overdose

Europe - EMA - European Medicines Agency

8-8-2017

Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb)

Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb)

Paracetamol / ibuprofen 500 mg / 150 mg Film-coated tablets (Paracomb) (Active substance: paracetamol / ibuprofen) - Community Referrals - Art 29 - Commission Decision (2017) 5646 of Tue, 08 Aug 2017 European Medicines Agency (EMA) procedure number: EMEA/H/A-29(4)/1447

Europe -DG Health and Food Safety

28-7-2017

Scientific guideline:  Draft paracetamol oral use, immediate release formulations product-specific bioequivalence guidance - First version, draft: consultation open

Scientific guideline: Draft paracetamol oral use, immediate release formulations product-specific bioequivalence guidance - First version, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of paracetamol

Europe - EMA - European Medicines Agency